In addition to Iconoclast's excellent answer, combining 3-point MACE from past Phase 2 trials wouldn't add many 3-point MACE to the BETonMACE tally. By my count, ASSURE and SUSTAIN only documented 8 total 3-point MACE events in the total population; only 3 3-point MACE in the diabetics. Most events in the Phase 2 post-hoc analyses were the "soft" coronary revascularization/hospitalization for unstable angina or heart failure category. 

BDAZ